Literature DB >> 10325658

Cytokine production by synovial T cells in rheumatoid arthritis.

G Steiner1, M Tohidast-Akrad, G Witzmann, M Vesely, A Studnicka-Benke, A Gal, M Kunaver, P Zenz, J S Smolen.   

Abstract

OBJECTIVE: To investigate the production of cytokines by T cells in patients with rheumatoid arthritis (RA), reactive arthritis (REA) and osteoarthritis (OA).
METHODS: The lymphokines interleukin (IL)-2, IL-4, interferon gamma (IFN-gamma) and tumour necrosis factor beta (TNF-beta), as well as the monokines IL-1, IL-6 and TNF-alpha, were measured by immunoassays in sera and synovial fluid (SF) from patients with RA, REA and OA. In addition, cytokine expression was studied by immunohistochemistry in synovial membrane tissue sections from patients with RA and OA.
RESULTS: Almost 60% of RA sera contained at least one of the cytokines investigated, though in low concentrations, whereas cytokines were generally not detectable in sera from REA and OA patients. In contrast, cytokines were found in virtually all SF; thus, the majority of SF from RA patients contained IFN-gamma (median level 17 pg/ml) in addition to the monokines IL-6 (4700 pg/ml) and TNF-alpha (157 pg/ml). IFN-gamma and IL-6 (but not TNF-alpha) were also frequently measured in SF from REA patients, whereas OA samples typically contained only IL-6. Immunohistochemical analysis of tissue sections from RA patients revealed lymphokine expression in 0.1-0.3% of T cells, particularly IL-2 and IFN-gamma, and to a lesser extent also IL-4. Interestingly, the expression of TNF-alpha and IL-6 by synovial T cells was also observed. The majority of cytokine-expressing T cells were CD4-positive T-helper cells typically found in perivascular areas, whereas cytokine-producing CD8-positive T cells were found distributed throughout the synovium. As expected, in specimens from OA patients, T cells were much less abundant and expression of cytokines could not be detected.
CONCLUSION: These data clearly demonstrate production of cytokines by T cells in RA synovial tissue, indicating that activated T cells play a role in the pathophysiological events of RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10325658     DOI: 10.1093/rheumatology/38.3.202

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  61 in total

Review 1.  Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis?

Authors:  Louise C Pollard
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Cyclic adenosine 5'-monophosphate in synovial fluid of rheumatoid arthritis and osteoarthritis patients.

Authors:  Jadranka Morovic-Vergles; Melanie Ivana Culo; Stjepan Gamulin; Filip Culo
Journal:  Rheumatol Int       Date:  2008-08-10       Impact factor: 2.631

Review 3.  Interleukin-23 as a potential therapeutic target for rheumatoid arthritis.

Authors:  Chao Rong; Wei Hu; Fan-rong Wu; Xiao-juan Cao; Fei-hu Chen
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

4.  All-trans-retinoic acid suppresses interferon-gamma and tumor necrosis factor-alpha; a possible therapeutic agent for rheumatoid arthritis.

Authors:  Yuji Nozaki; Chise Tamaki; Toshiaki Yamagata; Masafumi Sugiyama; Shinya Ikoma; Koji Kinoshita; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2005-11-15       Impact factor: 2.631

5.  Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells.

Authors:  Paul A Beavis; Bernard Gregory; Patricia Green; Adam P Cribbs; Alan Kennedy; Parisa Amjadi; Andrew C Palfreeman; Marc Feldmann; Fionula M Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-16       Impact factor: 11.205

6.  IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Rachel L Rodeghero; Katalin Mikecz; Tibor T Glant; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2009-12-18       Impact factor: 5.422

7.  Cytokine profile in serum and synovial fluid of arthritis patients with Chlamydia trachomatis infection.

Authors:  Michael C Jendro; Elke Raum; Sebastian Schnarr; Lars Köhler; Henning Zeidler; Jens G Kuipers; Michael Martin
Journal:  Rheumatol Int       Date:  2003-10-31       Impact factor: 2.631

8.  Leflunomide in active rheumatoid arthritis: a prospective study in daily practice.

Authors:  E N Van Roon; T L Th A Jansen; L Mourad; P M Houtman; G A W Bruyn; E N Griep; B Wilffert; H Tobi; J R B J Brouwers
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

9.  Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis.

Authors:  S M Nanjundaiah; J P Stains; K D Moudgil
Journal:  Int J Immunopathol Pharmacol       Date:  2013 Jan-Mar       Impact factor: 3.219

10.  Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model.

Authors:  Mi Ra Chang; Brent Lyda; Theodore M Kamenecka; Patrick R Griffin
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.